Bioinformatics has been an important approach to explore the role of targets in LUAD and their mechanisms.[19] Among the potential targets, KIFC1, a kinesin-14 motor protein, has garnered attention due to its upregulation in multiple cancer types and its involvement in oncogenic signaling pathways.[8,20] Consequently, KIFC1 has emerged as a promising candidate for targeted chemotherapies. This evidence concerns the gene KIFC1 and cancer.